Merck is ending Phase 3 trial of Winrevair (sotatercept) early due to positive interim results in treating pulmonary arterial ...

Is this the end for Cassava Sciences? After a problematic development path riddled with allegations of misleading investors, ...

Incyte’s monoclonal antibody Monjuvi reduced certain follicular lymphoma patients’ risk of progression, relapse or death by ...

Biohaven's Phase 3 trial of taldefgrobep alfa failed to meet its primary endpoint in spinal muscular atrophy, causing a 10% ...

Gilead acquires HTI T-cell immunogen HIV vaccines from Barcelona's Aelix Therapeutics for an undisclosed amount. The vaccines ...

After recently discontinuing R&D for Truqap in triple-negative breast cancer, AstraZeneca has some good news on its kinase ...

Replimune announces $125M offering after FDA submission for RP1; Otsuka partners with Ionis on ALS drug ulefnersen; Kanglin Biotechnology raises $20M; Seelos files bankruptcy; Orbus reports positive ...

Former Florida congressman Dave Weldon is President-elect Donald Trump’s pick to lead the CDC, giving Robert F. Kennedy Jr. a ...

Sanofi is proposing a new model for distributing drug discounts under the federal 340B program, according to the Wall Street ...

Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of ...

The Senate Judiciary Committee narrowly advanced a bill Thursday that would change the way the Patent Trial and Appeal Board ...

As the healthcare priorities of President-elect Donald Trump and his HHS pick Robert F. Kennedy Jr. take shape, one idea ...